Clinical application of drug screening in circulating tumor cells in patients with breast cancers
Not Applicable
Completed
- Conditions
- Clinical application of drug screening in circulating tumor cells in patients with breast cancersCancer
- Registration Number
- ISRCTN10116660
- Lead Sponsor
- inkou Chang Gung Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 34
Inclusion Criteria
Newly diagnosed primary locally advanced female breast cancer patients
Exclusion Criteria
1. Participants undergoing primary surgery
2. Without informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation between anti-cancer drug tests and patient's clinical outcome measured using data collected from patient medical records as the evaluation of drug response between baseline and 3 to 6 months after treatment
- Secondary Outcome Measures
Name Time Method The prognostic and predictive role of the count of circulating tumor cells (CTCs) measured using a fluorescence microscope to count CTCs and CTC-white blood cells (WBCs) at baseline, 3 to 6 months after treatment<br> <br>